CD274 and non-small cell lung carcinoma: Secreted PD-L1 (secPD-L1), either soluble (sPD-L1) or presented by exosomes (exoPD-L1), is recently shown to have prognostic and predictive importance for NSCLC immunotherapy [29,30,31,32].